Rathke's Cleft Cyst Clinical Trial
— PREVA-KPROfficial title:
Evaluation of the Pravalence of Rathke's Cleft Cyst of Children Under 15 Years
| Verified date | May 2019 |
| Source | Centre Hospitalier Universitaire de Besancon |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The goal of the study was to evaluate the pravalence of Rathke's Cleft Cyst of children under 15 years of age and demonstrate that their prevalence is higher than for patients over 15 years of age, due to their embryonic origin. It is also aimed to describe their aspect on MRI and evaluate the interobserver agreement in the detection of Rathke's Cleft Cyst.
| Status | Completed |
| Enrollment | 460 |
| Est. completion date | November 1, 2018 |
| Est. primary completion date | November 1, 2018 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - children aged 15 or under at the time that an MRI was performed exploring the sellar region - MRI with at least T1 spin echo (SE) sagittal slices with a slice thickness of 2.5 or 3 mm with inter-slice spacing of 0.3 mm and T2 SE with a slice thickness of 2 mm and inter-slice spacing of 0.2 mm. Exclusion Criteria: - Patients with incomplete MRI protocol - Patients whose MRI images had artifacts (patient movement, presence of dental material) - Patients with suspected pituitary pathology due to endocrine symptomatology (growth retardation, puberty delay, diabetes insipidus) that could be attributed to an intrasellar injury were also excluded. |
| Country | Name | City | State |
|---|---|---|---|
| France | Centre Hospitalier Universitaire | Besançon |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Besancon |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Presence or absence of a strictly intra-pituitary cystic lesion which localization and signal was compatible with an RCC, which type was defined according to its signal | All MRI performed on a period of one year in children under 15 years will be taken into account | ||
| Secondary | Maximum anteroposterior diameter (parallel to the bi-callous plane) of the cyst measured in sagittal section | All MRI performed on a period of one year in children under 15 years will be taken into account | ||
| Secondary | Cyst signal on T2-weighted spin echo sequence compared to cerebrospinal fluid (hypo / iso / hyper signal) and T1-weighted compared to cerebral white matter (hypo / iso / hyper signal) | All MRI performed on a period of one year in children under 15 years will be taken into account | ||
| Secondary | Motive for which brain MRI was performed | The motive can be: benign tumoral pathology neurological manifestations traumatic pathologies other pathologies (deterioration of the general state, exophthalmia). |
All MRI performed on a period of one year in children under 15 years will be taken into account | |
| Secondary | Dimensions of pituitary | All MRI performed on a period of one year in children under 15 years will be taken into account |